| TTM
|
6/30/2026
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
48,130 | 48,130 | 37,773 | 0 | 0 |
| Cost of Revenue
|
-40,241 | -40,241 | -31,264 | 0 | -15,499 |
|
Gross Profit
|
7,889 | 7,889 | 6,509 | 0 | 3,301 |
| Selling, General and Administrative Expenses
|
-11,589 | -11,589 | -13,226 | -3,519 | -2,442 |
|
Operating Income/Expenses
|
-11,589 | -11,589 | -13,226 | -3,519 | -2,442 |
|
Total Operating Profit/Loss
|
-3,700 | -3,700 | -6,717 | -3,519 | -2,442 |
| Total Net Finance Income/Expense
|
-3,652 | -3,652 | -2,969 | 518 | 154 |
| Net Investment Income
|
-419 | -419 | 400 | 0 | -- |
| Irregular Income/Expenses
|
-6,160 | -6,160 | 0 | -- | 12,000 |
|
Other Income/Expense, Non-Operating
|
-31 | -31 | 56 | 0 | 222 |
|
Non-Operating Income/Expenses, Total
|
-10,262 | -10,262 | -2,513 | 518 | 154 |
|
Pretax Income
|
-13,962 | -13,962 | -9,230 | -3,001 | -2,288 |
|
Provision for Income Tax
|
579 | 579 | 2,329 | -20 | -6 |
|
Net Income from Continuing Operations
|
-13,383 | -13,383 | -6,901 | -3,021 | -2,294 |
|
Discontinued Operations
|
0 | 0 | 224 | 5,435 | 12,340 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-13,383 | -13,383 | -6,677 | 2,414 | 10,046 |
|
Non-Controlling/Minority Interests
|
2,203 | 2,203 | 934 | 0 | -- |
|
Net Income after Non-Controlling/Minority Interests
|
-11,180 | -11,180 | -5,743 | 2,414 | 10,046 |
|
Net Income Available to Common Stockholders
|
-11,180 | -11,180 | -5,743 | 2,414 | 10,046 |
|
Diluted Net Income Available to Common Stockholders
|
-11,180 | -11,180 | -5,743 | 2,414 | 10,046 |
| Basic EPS
|
-4.43 | -4.43 | -3.05 | 1.28 | 5.27 |
| Diluted EPS
|
-4.43 | -4.43 | -3.05 | 1.28 | 5.27 |
|
Basic Weighted Average Shares Outstanding
|
2,521 | 2,521 | 1,883.0610 | 1,894.7640 | 1,905.4020 |
|
Diluted Weighted Average Shares Outstanding
|
2,521 | 2,521 | 1,883.0610 | 1,894.7640 | 1,905.4020 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-10,310 | -10,310 | -6,261 | -3,519 | -2,442 |
|
EBITDA
|
-6,681 | -6,681 | -3,620 | -3,512 | -2,442 |
|
Normalized EBITDA
|
-521 | -521 | 1,013 | -3,512 | -2,319 |
|
Normalized Income
|
-5,017.1660 | -5,017.1660 | -6,856.1200 | -2,986.2400 | -2,196.8300 |
|
Total Unusual Items
|
8,248 | 8,248 | 60 | 44 | 123 |
12/31/2022 - 6/25/1991
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade